(Date:11/19/2009)...ewswire/ -- Dr. Mate Hidvegi, inventor of Avemar f...elease issued on November 17 by Biropharma Kft, di...and self-serving statements about its U.S. competi...d from his office in Budapest, Hungary: ,, "Th...t apply to AveULTRA, www.aveultra.com , is misl...
(Date:11/19/2009)...e-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ...ter to its shareholders, discussing the Company,s ...maceuticals Holdings, Inc. (CHBP), an integrated b...public of China. The merger gives NeoStem a contro...o. Ltd., CHBP,s primary operating subsidiary and a...
(Date:11/19/2009)..., Mass., Nov. 19 Arlington Medical...the leading driver of antibiotic selection in noso...ity against gram-positive and gram-negative pathog...e nosocomial pneumonia, surveyed European physicia... provide appropriate coverage against common patho...
(Date:11/19/2009)...e/ - Aegera Therapeutics Inc. announced today the ...2B study of AEG35156, a targeted antisense therape...y indications. ,, The study, entitled "An Open-...ibitor of Apoptosis (XIAP) Antisense AEG35156 Give...rubicin in AML Following Failure of a Single Stand...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2... Based on its recent analysis of the cell imaging ...nopoint, Inc. with the 2009 North American Frost &...Year. The company,s cellTRAY(R) Imaging System CT-...ope incubator and integrated fluidics system for i....com/cgi-bin/prnh/20081117/FSLOGO ) , , Cellular ...
...ill Invest in Biotech Start-up Companies Focused o...ENEVA, March 23 Merck Serono, a division of Merck...mation of ,Merck Serono Ventures, a strategic, cor...biotechnology companies. The fund will support bio... provide innovative products in Merck Serono,s cor...
...hough naturally occurring smallpox was eradicated ... obtain smallpox from a laboratory and release it ... supply of smallpox vaccine may be insufficient fo...n the December 2008 issue of The American Journal...tection is obtained from just one vaccination, eve...
Other Biology Technology:Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 2Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 3Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 4Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000 5Merck Serono Launches Strategic Venture Capital Fund 2Merck Serono Launches Strategic Venture Capital Fund 3New study indicates smallpox vaccination effective for decades 2Mouse Anti-Mouse Qa-1 Monoclonal Antibody, Unconjugated, Clone 6A8.6F10 from Santa Cruz Biotechnology, Inc.
6% PAGE/Urea Solution (19:1 Acrylamide/Bis + 6 M Urea) from Ambion
Rabbit Anti-CDV-1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
COX-1 Blocking Peptide from Cayman Chemical
Biology Products: